Texas Yale Capital Corp’s Allergan Inc AGN Stock Holding History

Texas Yale Capital Corp’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,295	Closed	-$700K	–	493
2014 Q4	$700K	Buy	+3,295	New	+$655K	0.06%	257

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Texas Yale Capital Corp's AGN Position: Q1 2015 in Review

Texas Yale Capital Corp sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 3,295 shares — an estimated $700K sold.

Texas Yale Capital Corp first reported a position in AGN in Q4 2014 and held it in 1 quarter. The position peaked at $700K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Texas Yale Capital Corp reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Texas Yale Capital Corp sold 3,295 Allergan Inc shares in Q1 2015, an estimated $700K.
Texas Yale Capital Corp first reported a position in Allergan Inc in Q4 2014 and held it in 1 quarter.
Texas Yale Capital Corp's Allergan Inc position peaked at $700K in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Texas Yale Capital Corp's 13F filing for Q1 2015, filed 16 Apr 2015.